Thermo Fisher Scientific Inc / PPD Inc

The CMA investigated and cleared the anticipated acquisition by Thermo Fisher Scientific Inc of PPD, Inc.

• From: Competition and Markets Authority
• Published: 15 October 2021
• Last updated: 7 February 2022 — See all updates

• Case type: Mergers
• Case state: Closed
• Market sector: Healthcare and medical equipment
• Outcome: Mergers - phase 1 clearance
• Closed: 3 December 2021

Statutory timetable

Phase 1	Action
3 December 2021	Decision announced
15 October 2021	Launch of merger inquiry
15 October 2021 to 1 November 2021	Invitation to comment

Phase 1

CMA clearance decision

3 December 2021: The CMA has cleared the anticipated acquisition by Thermo Fisher Scientific Inc. of PPD, Inc.

• Full text decision (7.2.22)

Launch of merger inquiry

15 October 2021: The CMA announced the launch of its merger inquiry by notice to the Parties.

• Commencement notice (15.10.21)

Invitation to comment: closes 1 November 2021

15 October 2021: The Competition and Markets Authority (CMA) is considering whether it is or may be the case that this transaction, if carried into effect, will result in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2002 and, if so, whether the creation of that situation may be expected to result in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services.

To assist it with this assessment, the CMA invites comments on the transaction from any interested party.

These comments should be provided by the deadline set out above.

Contact

Please send written representations about any competition issues to: [email protected]

Published 15 October 2021
Last updated 7 February 2022 + show all updates

1. 7 February 2022

   Full text of the clearance decision published.

2. 3 December 2021

   Phase 1 clearance decision published.

3. 15 October 2021

   First published.